Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cancer Research UK (CRUK) has awarded £9m to the University of Oxford, to support the next generation of doctors and scientists to bring novel cancer treatments to patients.

Cancer cells

CRUK is to award the funding over the next five years to train early-career clinician scientists - doctors who also carry out medical research - as part of its Clinical Academic Training Programme.

The Clinical Academic Training Programme will invest £58.7m at nine research centres, including the Cancer Research UK Oxford Centre.

Clinician scientists play an essential role in translating cancer research, helping to bridge the gap between scientific research carried out in laboratories and clinical research involving patients.

Working across both research settings, their contributions to new knowledge and its translation to clinical practice are critical for cancer research.

Read the full story on the University of Oxford website